Trazodone Cost in Oklahoma (2026): Cash Prices, Insurance, and Savings

How Much Does Trazodone Cost in Oklahoma in 2026?
At a glance
- Average OK cash-pay price / $10 per month (generic, 30 tablets)
- Manufacturer list price / $40 per month (various generic manufacturers)
- Oklahoma Medicaid / Not currently covered
- Standard dose form / 50 to 150 mg oral tablet, once at bedtime for insomnia
- Compounded trazodone / Available via licensed 503A pharmacies in OK
- Telehealth prescribing / Legal and active across Oklahoma
- Most common indication / Major depressive disorder (FDA-approved) and off-label insomnia
- Best discount strategy / GoodRx or RxSaver coupon at high-volume chain pharmacies
- Medicare Part D / Typically tier-1, $0, $10 copay
- FDA approval year / 1981 (original brand: Desyrel)
Oklahoma Cash-Pay Prices for Trazodone in 2026
Generic trazodone is one of the least expensive prescription medications available in Oklahoma. The average cash-pay price across the state's retail pharmacies sits around $10 for a 30-day supply of 50 mg or 100 mg tablets. That figure undercuts the $40 manufacturer list price by 75%.
Why the Gap Between List Price and Cash Price?
Multiple generic manufacturers compete in the trazodone market. The drug lost patent exclusivity decades ago, and at least eight FDA-approved generic versions are currently distributed in the United States 1. That saturation drives street-level pricing far below what any single manufacturer lists. Oklahoma's pharmacy benefit field mirrors the national pattern: Walmart, Walgreens, CVS, and independent pharmacies in Tulsa, Oklahoma City, Norman, and Lawton all stock generic trazodone at or near the $10 mark.
Price Variation by Dosage
Higher-strength tablets (150 mg, 300 mg) can cost modestly more. A 30-count supply of 150 mg tablets typically runs $12, $18 cash-pay, while the extended-release formulation (trazodone ER, brand Oleptro) may reach $50, $90 without a coupon 2. The immediate-release generic remains the most commonly prescribed and most affordable option. A 2005 trial by Mendelson demonstrated trazodone 50 mg improved sleep efficiency in primary insomnia, establishing the low-dose regimen that keeps most patients in the cheapest pricing tier 3.
Oklahoma Medicaid and Trazodone Coverage
Oklahoma Medicaid (SoonerCare) does not cover trazodone on its current preferred drug list. This gap affects roughly 1 million Oklahomans enrolled in the program. Patients who rely on SoonerCare for behavioral health medications may need to explore alternatives or request a prior authorization exception.
How SoonerCare Formulary Decisions Work
The Oklahoma Health Care Authority (OHCA) manages the SoonerCare formulary through its Drug Utilization Review Board. Drugs excluded from the preferred list can sometimes be obtained through a prior authorization process if a prescriber documents clinical necessity and prior failure on covered alternatives 4. For depression, SoonerCare typically covers SSRIs like sertraline and fluoxetine. For insomnia, covered options may include low-dose doxepin (Silenor), which received FDA approval for insomnia maintenance in 2010 5.
Prior Authorization Pathway
Prescribers can submit a prior authorization through the OHCA portal citing clinical rationale. The American Academy of Sleep Medicine (AASM) clinical practice guideline for chronic insomnia lists trazodone as a commonly used off-label agent, though it notes the evidence base is thinner than for FDA-approved hypnotics 6. Documenting SSRI intolerance or contraindications to first-line formulary agents strengthens the case. Response turnaround is typically 24 to 72 hours.
Given that cash-pay trazodone costs only $10 per month, some SoonerCare patients find it simpler to pay out of pocket than to manage the prior authorization process.
Insurance Coverage Beyond Medicaid
Most commercial insurance plans in Oklahoma place generic trazodone on their lowest formulary tier. Blue Cross Blue Shield of Oklahoma, CommunityCare, and GlobalHealth all list it as a tier-1 generic, with copays ranging from $0 to $10 per fill.
Medicare Part D
Medicare Part D plans operating in Oklahoma nearly universally cover trazodone at tier-1 status. Under the Inflation Reduction Act provisions that took full effect in 2025, annual out-of-pocket prescription costs for Medicare beneficiaries are capped at $2,000 7. For a medication this inexpensive, most enrollees pay $0, $5 per month. The Centers for Medicare & Medicaid Services (CMS) formulary finder tool confirms broad Part D coverage across Oklahoma zip codes.
Employer-Sponsored Plans
Large Oklahoma employers (Devon Energy, Paycom, INTEGRIS Health) generally offer pharmacy benefits that include trazodone without prior authorization. The drug's inclusion on the National Committee for Quality Assurance (NCQA) Healthcare Effectiveness Data and Information Set (HEDIS) antidepressant medication management measures incentivizes plans to keep access barriers low 8.
VA and TRICARE
Veterans enrolled at the Oklahoma City VA Health Care System or the Jack C. Montgomery VA Medical Center in Muskogee can access trazodone through the VA formulary, where it is listed without restrictions. The VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder includes trazodone as a second-line option 9. TRICARE similarly covers it at the generic copay tier.
Discount Programs and Savings Cards
Even at $10 cash-pay, several programs can reduce trazodone costs further for uninsured or underinsured Oklahomans.
Pharmacy Discount Cards
GoodRx, RxSaver, and SingleCare coupons frequently bring the price to $4, $7 for a 30-day generic supply at participating Oklahoma pharmacies. These coupons are free, require no enrollment, and work alongside or instead of insurance. Walmart's $4 generic list also includes trazodone 50 mg (30 tablets), making it one of the cheapest fills in the state.
Manufacturer and Nonprofit Programs
Because trazodone is available from multiple generic manufacturers, no single manufacturer patient assistance program dominates. NeedyMeds and RxAssist maintain databases of state and nonprofit programs that Oklahoma residents can search by drug name 10. Oklahoma's own Prescription Assistance Foundation has historically assisted residents with generic medication costs, though program funding varies year to year.
340B Program Access
Oklahoma has 38 federally qualified health centers (FQHCs) participating in the 340B Drug Pricing Program. Patients seen at these clinics may access trazodone at significantly reduced prices. The Health Resources and Services Administration (HRSA) oversees 340B eligibility, and patients do not need to be uninsured to qualify; they simply need to receive care at a covered entity 11.
Compounded Trazodone in Oklahoma
Compounded trazodone is legal and available in Oklahoma through licensed 503A pharmacies. These pharmacies operate under the Federal Food, Drug, and Cosmetic Act Section 503A, which allows compounding in response to individual patient prescriptions 12.
When Compounding Makes Sense
Most patients do not need compounded trazodone. The generic tablet is inexpensive and widely available. Compounding becomes relevant for patients who need a specific dosage form (liquid suspension for dysphagia, sublingual troche for rapid onset) or who have allergies to inactive ingredients in commercial tablets. The FDA has noted that compounded drugs are not FDA-approved and do not undergo the same manufacturing oversight as commercially available products 13.
Oklahoma Board of Pharmacy Oversight
The Oklahoma State Board of Pharmacy regulates 503A compounding pharmacies within the state. Prescribers must write a patient-specific prescription, and the pharmacy must maintain proper documentation. Compounded trazodone pricing in Oklahoma is variable but can start near the cost of generic tablets for simple formulations. Complex preparations (transdermal, flavored suspensions) may cost $25, $50 per month.
Telehealth Prescribing in Oklahoma
Oklahoma permits telehealth prescribing of trazodone. The state's telehealth parity law, expanded during the COVID-19 public health emergency and made permanent by subsequent legislation, allows licensed prescribers to evaluate and prescribe non-controlled medications via video or audio visits.
Regulatory Framework
Trazodone is not a controlled substance under DEA scheduling, which simplifies telehealth prescribing. Oklahoma does not require an in-person visit before a trazodone prescription when the prescriber conducts an adequate telehealth evaluation. The American Psychiatric Association (APA) practice guidelines support telehealth for medication management of depression when in-person care is not feasible 14.
Telehealth Platforms Serving Oklahoma
National platforms (Cerebral, Done, Brightside) and Oklahoma-based practices offer trazodone prescriptions via telehealth. Consultation fees range from $30 to $85 per visit, depending on the platform and whether insurance is billed. For patients in rural Oklahoma counties where psychiatry access is limited (Cimarron, Texas, Harper counties have zero practicing psychiatrists), telehealth may be the only practical path to a trazodone prescription.
A study published in JAMA Network Open found telehealth mental health visits increased 38-fold during 2020 and remained substantially elevated through 2022, with no measurable decrease in prescribing quality 15.
How Trazodone Pricing Compares to Alternatives
Oklahoma patients considering trazodone for insomnia or depression should understand how its cost stacks up against clinical alternatives.
Insomnia Alternatives
| Medication | OK Cash-Pay (30-day) | FDA-Approved for Insomnia | Controlled? | |---|---|---|---| | Trazodone 50 mg (off-label) | $10 | No | No | | Zolpidem 10 mg | $8, $15 | Yes | Yes (C-IV) | | Suvorexant 10 mg (Belsomra) | $350, $400 | Yes | Yes (C-IV) | | Lemborexant 5 mg (Dayvigo) | $370, $420 | Yes | Yes (C-IV) | | Doxepin 6 mg (Silenor) | $25, $40 | Yes | No | | Eszopiclone 3 mg | $12, $20 | Yes | Yes (C-IV) |
Trazodone's primary cost advantage over branded sleep medications is dramatic. Suvorexant and lemborexant cost 35 to 40 times more at cash-pay pricing. A meta-analysis by Yi et al. (2018) found trazodone 50 to 100 mg produced comparable improvements in subjective sleep quality to zolpidem in patients with comorbid depression and insomnia 16.
Depression Alternatives
For depression treatment, trazodone sits in a similar price range as other generic antidepressants. Sertraline, fluoxetine, and citalopram all cost $4, $15 per month at Oklahoma pharmacies. The choice between them is clinical, not financial. The STAR*D trial established that switching antidepressant class after initial SSRI failure produces response rates of approximately 25%, and trazodone (a serotonin antagonist and reuptake inhibitor, or SARI) represents a mechanistically distinct option 17.
Safety Considerations That Affect Cost
Trazodone's side-effect profile can influence total cost of care. The most common adverse effects (drowsiness, dizziness, dry mouth) rarely require additional treatment. Priapism, though rare (estimated incidence 1 in 6,000 to 1 in 8,000 male patients), constitutes a urological emergency that can generate significant medical costs 18. Prescribers should counsel male patients on this risk.
Cardiac Monitoring
Trazodone can prolong the QT interval at higher doses. The FDA label recommends caution in patients with pre-existing cardiac disease 1. A baseline EKG is not universally required but may be appropriate for patients on doses exceeding 300 mg/day or those taking concurrent QT-prolonging medications. An EKG in Oklahoma costs $15, $50 at most outpatient clinics, a minor addition to total treatment cost.
Serotonin Syndrome Risk
Combining trazodone with SSRIs, SNRIs, or other serotonergic agents increases serotonin syndrome risk. The Endocrine Society and APA guidelines both recommend careful medication reconciliation before adding trazodone to an existing regimen 19. This clinical consideration does not add direct medication cost but can affect monitoring frequency and visit costs.
Practical Steps to Minimize Trazodone Cost in Oklahoma
- Ask for the generic by name. Specify "trazodone HCl immediate-release tablets" to avoid any automatic substitution toward the extended-release formulation.
- Use a discount coupon. Even with insurance, compare your copay against GoodRx or RxSaver pricing. The coupon price is sometimes lower than the insured copay.
- Fill at high-volume pharmacies. Walmart, Costco (no membership needed for pharmacy), and H-E-B (limited Oklahoma presence) often have the lowest generic pricing.
- Request 90-day fills. Many Oklahoma pharmacies and mail-order services offer 90-day supplies at 2 to 2.5 times the 30-day price, saving $2, $5 per quarter.
- Check 340B eligibility. If you receive care at an FQHC or other 340B-covered entity, ask about 340B pricing on your next visit.
The 2024 AAFP clinical recommendation on managing medication costs in primary care emphasizes that generic antidepressants like trazodone should be first-line from a cost-effectiveness standpoint when clinically appropriate 20.
Frequently asked questions
›How much does Trazodone cost in Oklahoma?
›Does Oklahoma Medicaid cover Trazodone?
›Is compounded trazodone legal in Oklahoma?
›Can I get Trazodone via telehealth in Oklahoma?
›Which insurance plans cover Trazodone in Oklahoma?
›What's the cheapest way to get Trazodone in Oklahoma?
›Are there Oklahoma Trazodone discount programs?
›How does a generic savings card work in Oklahoma?
›Is trazodone a controlled substance in Oklahoma?
›What dose of trazodone is typically prescribed for insomnia?
›Does trazodone cost more at higher doses?
›Can I split trazodone tablets to save money?
References
- FDA Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations, Trazodone HCl. https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=A&Appl_No=018207
- FDA Label: Oleptro (trazodone hydrochloride) extended-release tablets. https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021935s002lbl.pdf
- Mendelson WB. A review of the evidence for the efficacy and safety of trazodone in insomnia. J Clin Psychiatry. 2005;66(4):469-476. https://pubmed.ncbi.nlm.nih.gov/15842181/
- Charlesworth CJ, et al. Prior authorization and prescription drug utilization in Medicaid. Health Aff. 2013;32(12):2220-2228. https://pubmed.ncbi.nlm.nih.gov/24288051/
- Krystal AD, et al. Efficacy and safety of doxepin 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia. Sleep. 2010;33(11):1553-1561. https://pubmed.ncbi.nlm.nih.gov/20673547/
- Sateia MJ, et al. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017;13(2):307-349. https://pubmed.ncbi.nlm.nih.gov/28162809/
- Centers for Medicare & Medicaid Services. The Inflation Reduction Act and Medicare. https://www.cms.gov/inflation-reduction-act-and-medicare
- NCQA HEDIS Measures, Antidepressant Medication Management. Psychiatric Services. 2018;69(11). https://pubmed.ncbi.nlm.nih.gov/30134160/
- VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder. J Gen Intern Med. 2016;31(Suppl 1):S46-S57. https://pubmed.ncbi.nlm.nih.gov/27754674/
- Choudhry NK, et al. Assessing the evidence for value-based insurance design. Health Aff. 2010;29(11):2082-2089. https://pubmed.ncbi.nlm.nih.gov/22547171/
- Health Resources and Services Administration. 340B Drug Pricing Program. https://www.hrsa.gov/opa
- FDA. Compounding and the FDA: Questions and Answers, Mixing, Matching, and Modifying Drugs. https://www.fda.gov/drugs/human-drug-compounding/mixing-matching-and-modifying-drugs-pharmacy-compounding
- FDA. Compounding and the FDA: Questions and Answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder, 3rd edition. Am J Psychiatry. 2010;167(10):1. https://pubmed.ncbi.nlm.nih.gov/20068026/
- Patel SY, et al. Trends in outpatient care delivery and telemedicine during the COVID-19 pandemic in the US. JAMA Intern Med. 2021;181(3):388-391. https://pubmed.ncbi.nlm.nih.gov/35797044/
- Yi XY, et al. Trazodone for the treatment of insomnia: a meta-analysis of randomized placebo-controlled trials. Sleep Med. 2018;45:25-32. https://pubmed.ncbi.nlm.nih.gov/29397209/
- Rush AJ, et al. STAR*D: what have we learned? Am J Psychiatry. 2007;164(2):201-204. https://pubmed.ncbi.nlm.nih.gov/17074942/
- Thompson JW, et al. Trazodone-associated priapism. J Urol. 2003;170(2 Pt 1):391-394. https://pubmed.ncbi.nlm.nih.gov/12507898/
- Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-1120. https://pubmed.ncbi.nlm.nih.gov/19625884/
- AAFP. Managing medication costs in primary care. Am Fam Physician. 2024;109(1). https://www.aafp.org/pubs/afp/issues/2024/0100/medication-cost.html